Pharmacognosy · Analgesic & Antipyretic · Fr. Pharmacopoeia List A

Willow Bark

Salix alba (Salicaceae) — a dioecious tree common throughout Europe's humid habitats, whose bark contains salicin, the natural glycoside precursor that led directly to the discovery of aspirin. Used as an analgesic and antipyretic since antiquity, willow bark's salicylates are converted in the body to salicylic acid, the compound behind its traditional use for fever, pain, and joint inflammation. A related species, Salix purpurea, is noted as an even richer natural source of the same active compound.

21 Primary Refs
6 Properties
Bark Parts Used
✦ Researched
Last Updated August 2, 2026
Primary Source Wikiphyto · NCBI PubMed · Phytother Res
Family Salicaceae
French Pharmacopoeia List A · Salicaceae

Biological Overview

Willow trees are dioecious, common in humid areas throughout Europe. Young branches are flexible, with alternate, elongated to lanceolate leaves on short petioles and finely toothed margins. Flowers are unisexual, grouped into erect catkins borne on separate male (yellow stamens) and female (two green carpels) trees.

HabitDioecious Tree
Native RangeHumid Habitats, Europe
Salicoside ContentMin. 2% (Pharmeuropa)
Regulatory StatusFr. Pharmacopoeia List A
Botanical Classification

Taxonomy & Identification

Latin Name
Salix alba L.
Family
Salicaceae
Common Names
Willow Bark, White Willow, Osier Blanc
Parts Used
Bark (from branches 2–3 years old)
Richest Species
Salix purpurea (highest salicoside content)
Origin
Common in humid areas throughout Europe
Ethnobotany & Traditional Use

History & Tradition

Willow bark has been used as an analgesic and antipyretic since antiquity — the history behind the discovery of aspirin traces back more than 3,500 years. 2 Medical use of the bark is traced to Galen, and it appears independently in both Greek and Chinese medicine (the latter via weeping willow).

The first documented account of the bark's properties is credited to Edward Stone, whose 1763 letter to the Royal Society described its effectiveness against fevers. 1 The compound salicoside (salicin) was isolated by Leroux in 1830; its activity was further characterized by Serfaty's 1908 work.

Willow branches also supply osier for wickerwork (mainly from the non-medicinal Salix viminalis), but medicinal use draws specifically on bark harvested from branches 2–3 years old. Many willow species are usable provided a minimum salicoside content of 2% (per Pharmeuropa), with Salix purpurea noted as the richest source.

⚠ Species & Standardization Matter

Willow bark's medicinal value depends on species and standardization: the European standard requires a minimum salicoside content of 2%, and Salix purpurea is noted as the richest natural source.

Timeline

Ancient Analgesic Use

Antiquity

Used as an analgesic and antipyretic since antiquity, with medical use traced to Galen and appearing in both Greek and Chinese medicine.

First Clinical Account

1763

Edward Stone's letter to the Royal Society gave the first documented clinical account of willow bark's fever-reducing properties.

Salicoside Isolated

1830

Leroux isolated the compound salicoside (salicin), with its biological activity further described in later work by Serfaty.

Aspirin's Willow Lineage & Modern Trials

19th Century–Present

Willow's salicylates led directly to the synthesis of aspirin, and modern meta-analyses have since confirmed willow bark's own analgesic effect in arthritis and back pain. 1718

The Key Molecule

Salicin (Salicoside) — Deep Dive

The glycoside "prodrug" behind willow bark's pain- and fever-reducing reputation — and the same pathway that led to the discovery of aspirin.

🧬

Prodrug Glycosides

Salicoside (salicin) and related compounds — salicortin, fragilin, populin, saliréposide, tremulacin — are glycoside "prodrugs" of salicylic acid, absorbed at more than 86% once ingested.

🔄

Intestinal Hydrolysis

Native salicoside is hydrolyzed in the intestine, while salicortin degrades more slowly — both pathways ultimately releasing salicyl alcohol (saligenin).

🧪

Hepatic Oxidation to Salicylic Acid

Saligenin undergoes intrahepatic oxidation to salicylic acid — the active compound responsible for willow bark's anti-inflammatory and analgesic action.

⏳

Absorption Slowed by Co-occurring Glycosides

Populin and tremulacin slow the absorption of the active salicylates, contributing to willow bark's gentler onset compared with synthetic salicylates.

⚠ Not the Same as Aspirin

Same pathway, weaker platelet effect.

Willow bark's salicylic acid acts less on thromboxane A2 synthesis than aspirin, giving it a weaker antiplatelet effect — and because natural salicylate content varies by species and bark age, it shouldn't be assumed equivalent to a measured aspirin dose.

Pharmaceutical Preparations

Parts Used & Available Forms

The bark is the only part used medicinally, prepared across four standardized forms.

Mother Tincture

Alcohol-based tincture of the bark, used at practitioner-directed dilution.

Mother Tincture

Standardized Plant Extract

Fresh-plant standardized extract (EPS) of the bark, offering consistent salicoside content.

Standardized Extract

Dry Extract

Concentrated dry bark extract, used for standardized salicoside dosing.

Dry Extract

Bark Decoction

Traditional decoction of the dried bark, briefly boiled and strained.

Decoction

Clinical Dosimetry

Dosages

Dosing reflects traditional and standardized-extract practice for the bark; duration and monitoring should be set by a qualified practitioner.

Form Dose Frequency Context Notes
Standardized Extract (by Salicoside) 60–120 mg Daily Standardized dosing Dosed to total salicoside content rather than raw bark weight.
Dried Bark (Decoction) 2–3 g Per preparation Traditional use Add to cold water, bring to a boil, strain after 5 minutes.
Phytochemistry

Composition

Bark composition only — no gemmotherapy (bud) or essential-oil fraction is documented for this species.

Bark — Primary Constituents

SalicylatesSalicoside (salicin), salicortin, fragilin, populin, saliréposide, tremulacin 3
1.5–11%
Phenolic CompoundsTriandrin, vimaline, saligenin, syringaldehyde, salicylic acid, p-hydroxybenzoic, caffeic, ferulic, and p-coumaric acids
Present
FlavonoidsHeterosides of quercetol, luteolin, eriodictyol, naringenin, ampelopsin, and isosalipurposide
Present
TanninsDimeric and trimeric proanthocyanidols
8–20%
PiceineMinor glycoside constituent 3
Present

Plant Properties — Pharmacodynamics

Six pharmacodynamic properties are documented for willow bark, anchored primarily in its salicin–salicylic acid pathway.

6 Properties Analgesic Anti-inflammatory Clinical + Preclinical
🔥

Anti-inflammatory

Reduces IL-6 and TNF-α (via apigenin and quercetin), lowers polynuclear cell infiltration, and reduces markers of joint tissue inflammation. 456

💊

Analgesic

Clinical trials support an antalgic effect in osteoarthritis and other pain conditions, alongside a long traditional record. 8910

🌡️

Antipyretic

Reduces fever through the same salicylic acid pathway responsible for its anti-inflammatory and analgesic action. 11

🦴

Antirheumatic

Used for rheumatic flare-ups and joint pain, with pain-management studies specifically supporting antirheumatic use. 16

🧫

Antiproliferative

Standardized bark extract (STW 33-I) shows antiproliferative activity in vitro. 14

🛡️

Antiseptic

Traditionally regarded as mildly antiseptic, alongside its analgesic and antipyretic actions.

Clinical Applications

Clinical Indications

Willow bark's traditional use spans mild fevers, joint and rheumatic pain, back pain, and general pain conditions.

🌡️
Mild Fevers & Colds
Primary Indication
  • Mild Fevers: Traditionally used for mild fevers, including those of flu-related origin, and common colds.
🦴
Rheumatic & Joint Pain
Primary Indication
  • Rheumatism & Joint Pain: Used for rheumatic flare-ups and joint pain; a meta-analysis shows genuine analgesic efficacy in arthritis with very few adverse effects. 17
  • Back Pain: Systematic review supports use for musculoskeletal back pain. 18
🩹
General Pain Conditions
Traditional Indication
  • Various Pain Types: Traditionally used for dysmenorrhea, headaches, dental pain, and other general pain conditions.
⚠️
Use Considerations
Clinical Precautions
  • Anticoagulant Caution: Use with care in patients taking anticoagulants or antiplatelet drugs. 19
  • Warfarin Interaction: A documented interaction with warfarin has been reported. 20
Pharmacodynamics

Mode of Action

Willow bark's anti-inflammatory and analgesic effects converge on the same salicylic acid pathway as aspirin, with additional cartilage-protective activity.

🧪

COX-1 / COX-2 Inhibition

Like aspirin, salicylic acid inhibits cyclooxygenase COX-1 and COX-2, reducing biosynthesis of prostaglandins E1 and E2.

🩸

Weaker Antiplatelet Effect Than Aspirin

Salicylic acid acts less on thromboxane A2 synthesis than aspirin does, making willow bark a weaker antiplatelet agent despite sharing the same underlying pathway.

🧫

NF-κB & Cytokine Suppression

Willow bark extract reduces IL-6 and TNF-α (via apigenin and quercetin) and suppresses IL-1β-induced NF-κB activation in joint tissue, lowering downstream COX-2 and matrix metalloprotease expression. 57

🦴

Cartilage-Protective & Anabolic Effects

In combination with nettle leaf and rosehip, willow bark extract reversed IL-1β-induced downregulation of type II collagen, CSPG, β1-integrin, and SOX-9 expression, and stimulated new cartilage formation in chondrocyte models. 7

Risk Profile

Safety & Interactions

Willow bark's naturally low salicylate content gives it a comparatively mild safety profile, though anticoagulant interactions and salicylate allergy remain genuine precautions.

⚠ Genuine Risks Specific to This Plant

Read Before Using Willow Bark

  • Anticoagulant & antiplatelet interaction: use with caution in patients taking anticoagulants or antiplatelet drugs, including a documented interaction with warfarin. 1920
  • Salicylate allergy: allergy to salicylates cannot be excluded, estimated to affect around 0.2% of the population.
  • Not a substitute for measured aspirin dosing: because natural salicylate content varies by species and bark age, willow bark should not be assumed equivalent to a specific aspirin dose.
  • GI effects from tannins: possible gastrointestinal disturbances are attributed to the tannin content rather than the salicylates themselves.
✓ How to Use Willow Bark More Safely

A Practical Safety Checklist

  1. Check for salicylate allergy. Avoid if you have known aspirin or salicylate sensitivity.
  2. Avoid with blood thinners. Use caution with anticoagulant or antiplatelet medication, given documented interaction potential.
  3. Choose a standardized product. Look for extracts standardized to salicoside content (minimum 2%) rather than raw bark of unknown potency.
  4. Watch for GI upset. Tannin content can cause mild stomach discomfort in some people; take with food if needed.
  5. Don't double up with aspirin or NSAIDs. Avoid combining without medical guidance, since both act on the same pathway.
  6. Talk to a provider first if pregnant, breastfeeding, or on regular medication.
⚠️

Adverse Effects

  • Overall Low Incidence: adverse effects are minimal given willow bark's naturally low salicylate content, especially compared with NSAIDs and aspirin. 12
  • GI Disturbances: possible gastrointestinal effects attributed to tannin content.
  • Salicylate Allergy: cannot be excluded, estimated to affect around 0.2% of the population.
🚫

Contraindications & Interactions

  • Anticoagulants/Antiplatelets: use with caution in patients on these medications. 19
  • Warfarin: documented interaction potential reported. 20
  • General Caution: avoid combining with aspirin or NSAIDs without medical guidance, as both act on the same salicylate pathway.
Clinical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare provider before starting willow bark, particularly if you have a salicylate allergy, take anticoagulants, are pregnant, or are breastfeeding.
Common Questions

Frequently Asked Questions

What is willow bark used for?
Willow bark is traditionally used for mild fevers and colds, rheumatic and joint pain, back pain, and general pain conditions such as headache, dental pain, and dysmenorrhea.
How does willow bark relieve pain?
Its marker compound, salicoside (salicin), is hydrolyzed in the intestine and oxidized in the liver to salicylic acid, which inhibits COX-1 and COX-2 and reduces prostaglandin biosynthesis, alongside suppressing IL-1β-induced NF-κB activation and inflammatory cytokines.
What is salicin (salicoside)?
Salicoside is a glycoside making up roughly 1.5–11% of willow bark, acting as a natural prodrug that's converted in the body to salicylic acid — the same active pathway aspirin was originally derived from.
What is the typical willow bark dosage?
Standardized extracts are typically dosed to deliver 60–120 mg of salicoside daily. Traditional decoction uses about 2–3 g of dried bark added to cold water, brought to a boil, and strained after 5 minutes.
Is willow bark the same as aspirin?
Not exactly. Willow bark shares the same underlying salicylate pathway as aspirin, but its salicylic acid acts less on thromboxane A2 synthesis, giving it a weaker antiplatelet effect, and its natural salicylate content is lower and more variable than a measured aspirin dose.
Can I take willow bark with blood thinners?
Use caution. Willow bark should be used carefully in patients taking anticoagulants or antiplatelet drugs, and a documented interaction with warfarin has been reported.
Does willow bark help with arthritis?
A meta-analysis of randomized controlled trials found genuine analgesic efficacy for willow bark in arthritis with very few adverse effects, though the authors recommend continued study.
Is willow bark safe to use long-term?
Adverse effects appear minimal given willow bark's naturally low salicylate content compared with NSAIDs and aspirin, but salicylate allergy and interaction with anticoagulant medication remain relevant precautions for ongoing use.
Sources

Bibliography

1. Stone E. An account of the success of the bark of the willow in the cure of agues. Phil Trans R Soc. 1763;53:195–200.
DOI: 10.1098/rstl.1763.0033 →↩
2. Desborough MJR, Keeling DM. The aspirin story — from willow to wonder drug. Br J Haematol. 2017;177(5):674–683.
PubMed: PMID 28106908 →↩
3. Kammerer B, Kahlich R, Biegert C, Gleiter CH, Heide L. HPLC-MS/MS analysis of willow bark extracts contained in pharmaceutical preparations. Phytochem Anal. 2005;16(6):470–478.
PubMed: PMID 16315493 →↩
4. Beg S, Swain S, Hasan H, Barkat MA, Hussain MS. Systematic review of herbals as potential anti-inflammatory agents: recent advances, current clinical status and future perspectives. Pharmacogn Rev. 2011;5(10):120–137.
Full Text (PMC) →↩
5. Drummond EM, Harbourne N, Marete E, Martyn D, Jacquier J, O'Riordan D, Gibney ER. Inhibition of proinflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark. Phytother Res. 2013;27(4):588–594.
PubMed: PMID 22711544 →↩
6. Sharma S, Sahu D, Das HR, Sharma D. Amelioration of collagen-induced arthritis by Salix nigra bark extract via suppression of pro-inflammatory cytokines and oxidative stress. Food Chem Toxicol. 2011;49(12):3395–3406.
PubMed: PMID 21983485 →↩
7. Shakibaei M, Allaway D, Nebrich S, Mobasheri A. Botanical extracts from rosehip (Rosa canina), willow bark (Salix alba), and nettle leaf (Urtica dioica) suppress IL-1β-induced NF-κB activation in canine articular chondrocytes. Evid Based Complement Alternat Med. 2012;2012:509383.
PubMed: PMID 22474508 →↩
8. Schmid B, Lüdtke R, Selbmann HK, et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial. Phytother Res. 2001;15(4):344–350.
PubMed: PMID 11406860 →↩
9. Soeken KL. Selected CAM therapies for arthritis-related pain: the evidence from systematic reviews. Clin J Pain. 2004;20(1):13–18.
PubMed: PMID 14668651 →↩
10. Bartolini A, Di Cesare Mannelli L, Ghelardini C. Analgesic and antineuropathic drugs acting through central cholinergic mechanisms. Recent Pat CNS Drug Discov. 2011;6(2):119–140.
Full Text (PMC) →↩
11. Bonaterra GA, Heinrich EU, Kelber O, Weiser D, Metz J, Kinscherf R. Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv®) in LPS-activated human monocytes and differentiated macrophages. Phytomedicine. 2010;17(14):1106–1113.
PubMed: PMID 20570123 →↩
12. Shara M, Stohs SJ. Efficacy and safety of white willow bark (Salix alba) extracts. Phytother Res. 2015;29(8):1112–1116.
PubMed: PMID 25997859 →↩
13. Vlachojannis J, Magora F, Chrubasik S. Willow species and aspirin: different mechanism of actions. Phytother Res. 2011;25(7):1102–1104.
PubMed: PMID 21226125 →↩
14. Bonaterra GA, Kelber O, Weiser D, Metz J, Kinscherf R. In vitro anti-proliferative effects of the willow bark extract STW 33-I. Arzneimittelforschung. 2010;60(6):330–335.
PubMed: PMID 20648923 →↩
15. Calorio C, Donno D, Franchino C, Carabelli V, Marcantoni A. Bud extracts from Salix caprea L. inhibit voltage gated calcium channels and catecholamines secretion in mouse chromaffin cells. Phytomedicine. 2017;36:168–175.
PubMed: PMID 29157811 →↩
16. Chrubasik S, Pollak S. Pain management with herbal antirheumatic drugs. Wien Med Wochenschr. 2002;152(7-8):198–203.
PubMed: PMID 12017748 →↩
17. Lin CR, Tsai SHL, Wang C, Lee CL, Hung SW, Ting YT, Hung YC. Willow bark (Salix spp.) used for pain relief in arthritis: a meta-analysis of randomized controlled trials. Life (Basel). 2023;13(10):2058.
PubMed: PMID 37895439 →↩
18. Vlachojannis JE, Cameron M, Chrubasik S. A systematic review on the effectiveness of willow bark for musculoskeletal pain. Phytother Res. 2009;23(7):897–900.
PubMed: PMID 19140170 →↩
19. Altınterim B, Başar E. Effects of willow bark (Salix alba) and its salicylates on blood coagulant. Karaelmas Sci Eng J. 2013;3:37–39. DOI: 10.7212/zkufbd.v3i1.101.↩
20. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57(13):1221–1227.
PubMed: PMID 10902065 →↩

Additional Sources

Wichtl M, Anton R. Plantes thérapeutiques: Tradition, pratique officinale, science et thérapeutique. Tec & Doc, Cachan, 1999, p.491.